Skip to main content
Premium Trial:

Request an Annual Quote

FDA Renews License to GVK Bio’s Biomarker Database

Premium

GVK Biosciences said this week that the US Food and Drug Administration has renewed its license to the Hyderabad, India-based firm's clinical biomarker database.

GVK Bio said that the FDA’s biomarker qualification group renewed its license to the GVK BIO Online Biomarker Database, or GOBIOM, database.

GOBIOM contains clinically evaluated, exploratory, and preclinical biomarkers associated with different therapeutic areas that have been reported in global clinical trials, clinical, and preclinical studies.

Specifically, the resource contains data related to about 20,000 biochemical, genomic, imaging, metabolite, cellular, and physiological biomarkers as well as experimental, analytical, clinical, and statistical information.

The Scan

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.

Study Reviews Family, Provider Responses to Rapid Whole-Genome Sequencing Follow-up

Investigators identified in the European Journal of Human Genetics variable follow-up practices after rapid whole-genome sequencing.

BMI-Related Variants Show Age-Related Stability in UK Biobank Participants

Researchers followed body mass index variant stability with genomic structural equation modeling and genome-wide association studies of 40- to 72-year olds in PLOS Genetics.

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.